INGLES MARKETS INC-CLASS A (IMKTA) Stock Fundamental Analysis

NASDAQ:IMKTA • US4570301048

89.34 USD
+0.79 (+0.89%)
At close: Feb 13, 2026
89.34 USD
0 (0%)
After Hours: 2/13/2026, 8:17:20 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to IMKTA. IMKTA was compared to 38 industry peers in the Consumer Staples Distribution & Retail industry. The financial health of IMKTA is average, but there are quite some concerns on its profitability. IMKTA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • IMKTA had positive earnings in the past year.
  • IMKTA had a positive operating cash flow in the past year.
  • In the past 5 years IMKTA has always been profitable.
  • Each year in the past 5 years IMKTA had a positive operating cash flow.
IMKTA Yearly Net Income VS EBIT VS OCF VS FCFIMKTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • IMKTA has a Return On Assets (3.26%) which is comparable to the rest of the industry.
  • With a Return On Equity value of 5.17%, IMKTA is not doing good in the industry: 63.16% of the companies in the same industry are doing better.
  • With a Return On Invested Capital value of 3.86%, IMKTA perfoms like the industry average, outperforming 42.11% of the companies in the same industry.
Industry RankSector Rank
ROA 3.26%
ROE 5.17%
ROIC 3.86%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IMKTA Yearly ROA, ROE, ROICIMKTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • IMKTA has a Profit Margin (1.57%) which is comparable to the rest of the industry.
  • IMKTA's Profit Margin has declined in the last couple of years.
  • The Operating Margin of IMKTA (2.16%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of IMKTA has declined.
  • With a Gross Margin value of 23.89%, IMKTA perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of IMKTA has declined.
Industry RankSector Rank
OM 2.16%
PM (TTM) 1.57%
GM 23.89%
OM growth 3Y-31.14%
OM growth 5Y-18.48%
PM growth 3Y-31.16%
PM growth 5Y-16.56%
GM growth 3Y-1.42%
GM growth 5Y-1.67%
IMKTA Yearly Profit, Operating, Gross MarginsIMKTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IMKTA is destroying value.
  • There is no outstanding debt for IMKTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IMKTA Yearly Shares OutstandingIMKTA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
IMKTA Yearly Total Debt VS Total AssetsIMKTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 4.48 indicates that IMKTA is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.48, IMKTA is in the better half of the industry, outperforming 60.53% of the companies in the same industry.
  • IMKTA has a debt to FCF ratio of 13.06. This is a negative value and a sign of low solvency as IMKTA would need 13.06 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 13.06, IMKTA is doing worse than 68.42% of the companies in the same industry.
  • IMKTA has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
  • IMKTA's Debt to Equity ratio of 0.31 is fine compared to the rest of the industry. IMKTA outperforms 65.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 13.06
Altman-Z 4.48
ROIC/WACC0.46
WACC8.31%
IMKTA Yearly LT Debt VS Equity VS FCFIMKTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • IMKTA has a Current Ratio of 3.22. This indicates that IMKTA is financially healthy and has no problem in meeting its short term obligations.
  • IMKTA has a Current ratio of 3.22. This is amongst the best in the industry. IMKTA outperforms 94.74% of its industry peers.
  • A Quick Ratio of 1.63 indicates that IMKTA should not have too much problems paying its short term obligations.
  • IMKTA's Quick ratio of 1.63 is amongst the best of the industry. IMKTA outperforms 86.84% of its industry peers.
Industry RankSector Rank
Current Ratio 3.22
Quick Ratio 1.63
IMKTA Yearly Current Assets VS Current LiabilitesIMKTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 12.80% over the past year.
  • The Earnings Per Share has been growing by 40.11% on average over the past years. This is a very strong growth
  • Looking at the last year, IMKTA shows a quite strong growth in Revenue. The Revenue has grown by 13.85% in the last year.
  • IMKTA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.25% yearly.
EPS 1Y (TTM)12.8%
EPS 3Y52.74%
EPS 5Y40.11%
EPS Q2Q%70.11%
Revenue 1Y (TTM)13.85%
Revenue growth 3Y10.56%
Revenue growth 5Y7.25%
Sales Q2Q%6.59%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IMKTA Yearly Revenue VS EstimatesIMKTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
IMKTA Yearly EPS VS EstimatesIMKTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2022 5 10

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 6.23, the valuation of IMKTA can be described as very cheap.
  • Compared to the rest of the industry, the Price/Earnings ratio of IMKTA indicates a rather cheap valuation: IMKTA is cheaper than 92.11% of the companies listed in the same industry.
  • IMKTA is valuated cheaply when we compare the Price/Earnings ratio to 27.97, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.23
Fwd PE N/A
IMKTA Price Earnings VS Forward Price EarningsIMKTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IMKTA is valued a bit cheaper than 71.05% of the companies in the same industry.
  • 60.53% of the companies in the same industry are cheaper than IMKTA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 42.85
EV/EBITDA 7.7
IMKTA Per share dataIMKTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.16
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • IMKTA has a yearly dividend return of 0.76%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.70, IMKTA pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.79, IMKTA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.76%

5.2 History

  • The dividend of IMKTA has a limited annual growth rate of 0.12%.
  • IMKTA has been paying a dividend for at least 10 years, so it has a reliable track record.
  • IMKTA has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0.12%
Div Incr Years0
Div Non Decr Years11
IMKTA Yearly Dividends per shareIMKTA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • IMKTA pays out 14.68% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of IMKTA is growing, but earnings are growing more, so the dividend growth is sustainable.
DP14.68%
EPS Next 2YN/A
EPS Next 3YN/A
IMKTA Yearly Income VS Free CF VS DividendIMKTA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
IMKTA Dividend Payout.IMKTA Dividend Payout, showing the Payout Ratio.IMKTA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

INGLES MARKETS INC-CLASS A

NASDAQ:IMKTA (2/13/2026, 8:17:20 PM)

After market: 89.34 0 (0%)

89.34

+0.79 (+0.89%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)02-05
Earnings (Next)05-06
Inst Owners95.58%
Inst Owner Change-0.6%
Ins Owners0.08%
Ins Owner Change0%
Market Cap1.70B
Revenue(TTM)5.68B
Net Income(TTM)83.59M
Analysts84.44
Price TargetN/A
Short Float %7.1%
Short Ratio9.04
Dividend
Industry RankSector Rank
Dividend Yield 0.76%
Yearly Dividend0.65
Dividend Growth(5Y)0.12%
DP14.68%
Div Incr Years0
Div Non Decr Years11
Ex-Date01-08
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.23
Fwd PE N/A
P/S 0.32
P/FCF 42.85
P/OCF 11.01
P/B 1.05
P/tB 1.05
EV/EBITDA 7.7
EPS(TTM)14.35
EY16.06%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.09
FCFY2.33%
OCF(TTM)8.11
OCFY9.08%
SpS280.89
BVpS85.09
TBVpS85.09
PEG (NY)N/A
PEG (5Y)0.16
Graham Number165.76
Profitability
Industry RankSector Rank
ROA 3.26%
ROE 5.17%
ROCE 5.09%
ROIC 3.86%
ROICexc 4.61%
ROICexgc 4.61%
OM 2.16%
PM (TTM) 1.57%
GM 23.89%
FCFM 0.74%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-31.14%
OM growth 5Y-18.48%
PM growth 3Y-31.16%
PM growth 5Y-16.56%
GM growth 3Y-1.42%
GM growth 5Y-1.67%
F-Score6
Asset Turnover2.08
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 13.06
Debt/EBITDA 2.1
Cap/Depr 93.17%
Cap/Sales 2.15%
Interest Coverage 5.78
Cash Conversion 64.72%
Profit Quality 47.37%
Current Ratio 3.22
Quick Ratio 1.63
Altman-Z 4.48
F-Score6
WACC8.31%
ROIC/WACC0.46
Cap/Depr(3y)138.74%
Cap/Depr(5y)127.56%
Cap/Sales(3y)2.94%
Cap/Sales(5y)2.75%
Profit Quality(3y)46.78%
Profit Quality(5y)57.46%
High Growth Momentum
Growth
EPS 1Y (TTM)12.8%
EPS 3Y52.74%
EPS 5Y40.11%
EPS Q2Q%70.11%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.85%
Revenue growth 3Y10.56%
Revenue growth 5Y7.25%
Sales Q2Q%6.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-33.39%
EBIT growth 3Y-32.56%
EBIT growth 5Y-16.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-23.35%
FCF growth 3Y-43.53%
FCF growth 5Y-29.5%
OCF growth 1Y-41.3%
OCF growth 3Y-23.15%
OCF growth 5Y-15.14%

INGLES MARKETS INC-CLASS A / IMKTA FAQ

What is the fundamental rating for IMKTA stock?

ChartMill assigns a fundamental rating of 4 / 10 to IMKTA.


What is the valuation status for IMKTA stock?

ChartMill assigns a valuation rating of 3 / 10 to INGLES MARKETS INC-CLASS A (IMKTA). This can be considered as Overvalued.


How profitable is INGLES MARKETS INC-CLASS A (IMKTA) stock?

INGLES MARKETS INC-CLASS A (IMKTA) has a profitability rating of 3 / 10.


What is the valuation of INGLES MARKETS INC-CLASS A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for INGLES MARKETS INC-CLASS A (IMKTA) is 6.23 and the Price/Book (PB) ratio is 1.05.


How financially healthy is INGLES MARKETS INC-CLASS A?

The financial health rating of INGLES MARKETS INC-CLASS A (IMKTA) is 5 / 10.